Oxford Expression Technologies Company Profile

09:06 EDT 23rd March 2018 | BioPortfolio

Oxford Expression Technologies is a world-renowned centre of excellence for baculovirus protein expression. We provide protein expression products, services and consultancy to many global pharmaceutical companies and are now marketing commercial products based upon our world-beating flashBAC protein expression technologyOET was founded in 2000 by leading members of the School of Biological and Molecular Science at Oxford Brookes University and of NERC CEH Oxford. Our mission is to exploit innovative developments in the baculovirus protein expression system that have established the two institutes at the forefront of this technology.


Oxford Brookes UniversityGypsy Lane Campus
United Kingdom


Fax: (+44) 01865 483250

News Articles [809 Associated News Articles listed on BioPortfolio]

Oxford Genetics Licenses SnapFast™ Expression Vectors to Twist Bioscience

The post Oxford Genetics Licenses SnapFast™ Expression Vectors to Twist Bioscience appeared first on SynBioBeta.

Oxford Genetics Licenses Expression Vectors To CA-Based Twist Bioscience

NewsOxford will supply Twist with its SnapFast technology platform to provide a broad range of application-specific expression vectors. which will be used to clone synthesized DNA.

DNA Sequencing Unicorn Oxford Nanopore Raises £100M round at £1.5B valuation

Undeterred by competitors, Oxford Nanopore Technologies, one of the few unicorns in the biotech space, has secured £100M (€113M) to continue growing its unique next generation sequencing platform...

Oxford mothers-to-be learn about gestational diabetes research

Oxford researchers have attended two events in Oxford to let pregnant women know how to have a healthy pregnancy and to ask them to get involved in giving their views on future research. The researche...

Oxford Centre for Haematology launched

The new Oxford Centre for Haematology has been launched with funding from the NIHR Oxford Biomedical Research Centre (BRC), bringing together University of Oxford researchers and clinicians from Oxfor...

Oxford Nanopore Completes $140 Million Funding Led by Asian Investors

Oxford Nanopore Technologies, a UK company that offers several portable real-time DNA/RNA sequencers, completed a $140 million funding led by Asian investors. The investors were GIC (the Singapore sov...

Oxford Genetics announces adeno-associated virus collaboration with MeiraGTx

Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has established a new agreement with clinical-stage gene therapy company...

Oxford Nanopore's tech reaches genome sequencing landmark

A  new technique for gene sequencing has produced the most complete human genome ever assembled with a single technology - the nanapore, developed by UK company Oxford Nanopore Technologies. The m...

PubMed Articles [3499 Associated PubMed Articles listed on BioPortfolio]

SPRING: a kinetic interface for visualizing high dimensional single-cell expression data.

Single-cell gene expression profiling technologies can map the cell states in a tissue or organism. As these technologies become more common, there is a need for computational tools to explore the dat...

Identification and visualisation of differential isoform expression in RNA-seq time series.

As sequencing technologies improve their capacity to detect distinct transcripts of the same gene and to address complex experimental designs such as longitudinal studies, there is a need to develop s...

NanoPack: visualizing and processing long read sequencing data.

Here we describe NanoPack, a set of tools developed for visualization and processing of long read sequencing data from Oxford Nanopore Technologies and Pacific Biosciences.

A brief review of single-cell transcriptomic technologies.

In recent years, there has been an effort to develop new technologies for measuring gene expression and sequence information from thousands of individual cells. Large data sets that were obtained usin...

Conditional Degrons for Controlling Protein Expression at the Protein Level.

The conditional depletion of a protein of interest (POI) is useful not only for loss-of-function studies, but also for the modulation of biological pathways. Technologies that work at the level of DNA...

Clinical Trials [1847 Associated Clinical Trials listed on BioPortfolio]

Oxford Partial Knee Replacement. A Randomized Clinical Trial of Three Implant Types

The purpose of this scientific study is to clarify whether there is a relationship between the appearance of radiolucent lines in bone-cement interphase of the tibial component of the diff...

Comparison of Oxford UKA and Sigma UKA With RSA.

Comparison of two unicompartmental knee arthroplasties (UKA), to see if Sigma UKA performs equally good as the Oxford UKA. The study focuses on how well the arthroplasty is fixated to the ...

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in th...

Oxford® Partial Knee Kinematics Gait Analysis Study

The objective of this study is to compare the effect on gait of unicompartmental knee arthroplasty (UKA), using the Oxford® Partial Knee, versus total knee arthroplasty (TKA), using the V...

Outcome Analysis of the Oxford Partial Knee Arthroplasty

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

Companies [1603 Associated Companies listed on BioPortfolio]

Oxford Expression Technologies

Oxford Expression Technologies is a world-renowned centre of excellence for baculovirus protein expression. We provide protein expression products, services and consultancy to many global pharmaceutic...

Oxford Nanopore Technologies Ltd

Oxford Nanopore Technologies Ltd is developing a revolutionary technology for direct, electrical detection and analysis of single molecules. The platform is designed to offe...

Oxford Nanopore Technologies Ltd.

Oxford Nanopore Technologies Ltd is developing a novel technology for direct, electronic detection and analysis of single molecules using nanopores. The modular, scalable GridI...

Oxford Resource Partners, LP

Oxford Resource Partners, LP is a low cost producer of high value steam coal in Northern Appalachia and the Illinois Basin. Oxford markets its coal primarily to large electric utilities with coal-fir...

Oxford Healthcare Technology

Oxford Healthcare Technology is a staffing firm that leverages their recruiting expertise to deliver experienced healthcare professionals and project teams for consulting engageme...

More Information about "Oxford Expression Technologies" on BioPortfolio

We have published hundreds of Oxford Expression Technologies news stories on BioPortfolio along with dozens of Oxford Expression Technologies Clinical Trials and PubMed Articles about Oxford Expression Technologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxford Expression Technologies Companies in our database. You can also find out about relevant Oxford Expression Technologies Drugs and Medications on this site too.

Quick Search


Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Corporate Database Quicklinks

Searches Linking to this Company Record